{"title":"The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C","authors":"I. Rusu, Liliana Hodorogea, T. Holban","doi":"10.38045/ohrm.2020.1.02","DOIUrl":null,"url":null,"abstract":"assessment of hepatitis C and genotype, as well as the degree of hepatic fibrosis by Fibroscan, biochemical and complete blood count indices carried out. Results. The study results showed high efficacy of the generic DAAs treatment in patients with chronic HCV over 12 weeks. The SVR rate made up 90.3% in Sofosbuvir + Ledipasvir therapy and","PeriodicalId":34509,"journal":{"name":"One Health Risk Management","volume":"23 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"One Health Risk Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.38045/ohrm.2020.1.02","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
assessment of hepatitis C and genotype, as well as the degree of hepatic fibrosis by Fibroscan, biochemical and complete blood count indices carried out. Results. The study results showed high efficacy of the generic DAAs treatment in patients with chronic HCV over 12 weeks. The SVR rate made up 90.3% in Sofosbuvir + Ledipasvir therapy and
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
